Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan and LNAA in Phenylketonuria
NCT01617070Phase 4Completed
- Sponsor
- University of Southern California
- Start
- May 2012
- Primary completion
- Dec 2014
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of sapropterin in phenylketonuria (PKU), sponsored by University of Southern California. Started May 2012; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01617070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617070.